Startseite Risk factors for maternal colonization with group B beta-hemolytic streptococci
Artikel Öffentlich zugänglich

Risk factors for maternal colonization with group B beta-hemolytic streptococci

  • Richard R Terry , Francis W Kelly , Cheryl Gauzer und Melissa Jeitler
Veröffentlicht/Copyright: 1. November 1999

Published Online: 1999-November-01
Published in Print: 1999-November-01

© 1999 American Osteopathic Association

Artikel in diesem Heft

  1. New England Journal of Medicine article may be misleading about OMT
  2. What is the standard of care for patients with low back pain?
  3. Obesity article ignores surgery as possible option
  4. Response: Obesity article ignores surgery as possible option
  5. What's in a name?
  6. The importance of referencing osteopathic medical literature
  7. The dichotomy of overdosing or underdosing for pain
  8. From the NICHHD: Day care has impact on mother-child bond
  9. From the FDA: FDA allows soy health claim on food labels
  10. From the CDC: Obesity increases dramatically in the United States
  11. From the FDA: Abbott aggrees to correct manufacturing deficiencies
  12. From the FDA: Abbott aggrees to correct manufacturing deficiencies
  13. From the CDC: Flu, pneumonia shots urged
  14. From the CDC: Rotavirus vaccine withdrawn from market
  15. From the FDA: FDA approves Tamiflu for influenza
  16. From the CDC: Guidelines modified for meningitis vaccination
  17. Editorial comments
  18. Risk factors for maternal colonization with group B beta-hemolytic streptococci
  19. Multiple sclerosis--Part I. Overview pathophysiology, diagnostic evaluation, and clinical parameters
  20. Use of ketorolac in renal colic
  21. CME QUIZ
  22. Medi-notes: OMT versus standard care for patients with low back pain
  23. Heliobacter pylori in gastric carcinoma
  24. Editor's message
  25. The multisystem adverse effects of NSAID therapy
  26. COX-1 and COX-2 in health and disease
  27. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results
  28. COX-2-specific inhibition: Implications for clinical practice
Heruntergeladen am 15.10.2025 von https://www.degruyterbrill.com/document/doi/10.7556/jaoa.1999.99.11.571/html?lang=de
Button zum nach oben scrollen